{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-327575","form_type":"8-K","ticker":"SLN","cik":"0001479615","company_name":"Silence Therapeutics plc","filed_at":"2025-12-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.497279+00:00","generated_at":"2026-05-16T12:24:23.928665+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Silence Therapeutics appoints CFO Rhonda Hellums to Board of Directors effective Dec 18, 2025","bullets":["Rhonda Hellums, EVP and CFO, appointed as executive director effective December 18, 2025.","Her initial term runs until the 2026 Annual General Meeting of Shareholders.","Ms. Hellums will not receive additional compensation for board service.","She will not serve on any board committee.","No family relationships or material transactions requiring disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-327575","json":"https://secwatch.observer/filing/0001193125-25-327575.json","markdown":"https://secwatch.observer/filing/0001193125-25-327575.md","text":"https://secwatch.observer/filing/0001193125-25-327575.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479615/000119312525327575/0001193125-25-327575-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479615/000119312525327575/sln-20251218.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:24:23.928665+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}